Reviva Pharmaceuticals Announces Board and Officer Changes
Ticker: RVPH · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1742927
| Field | Detail |
|---|---|
| Company | Reviva Pharmaceuticals Holdings, Inc. (RVPH) |
| Form Type | 8-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, officer-departure, compensation
Related Tickers: RVPH
TL;DR
Reviva Pharmaceuticals (RVPH) board shake-up: new directors in, some execs out.
AI Summary
Reviva Pharmaceuticals Holdings, Inc. announced on February 13, 2025, a change in its board of directors. Specifically, the company reported the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for its officers. The filing details these changes as required by SEC regulations.
Why It Matters
Changes in a company's board and executive officers can signal shifts in strategy, operational focus, or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (company) — Registrant
- Tenzing Acquisition Corp. (company) — Former Company Name
- February 13, 2025 (date) — Date of earliest event reported
- February 18, 2025 (date) — Filing Date
FAQ
What specific roles have been affected by the departure of certain officers?
The filing indicates the departure of certain officers but does not specify the exact roles in this summary.
Who are the newly elected directors?
The filing states the election of directors but does not name them in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 13, 2025.
What is the company's primary business sector?
Reviva Pharmaceuticals Holdings, Inc. is in the Pharmaceutical Preparations sector (SIC code 2834).
What was the company's former name?
The company's former name was Tenzing Acquisition Corp., with a name change date of June 6, 2018.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).